Integra Lifesciences Holdings Corp (STU:IL3)
€ 16.4 +0.40 (+2.5%) Market Cap: 1.28 Bil Enterprise Value: 2.84 Bil PE Ratio: 0 PB Ratio: 1.40 GF Score: 74/100

Integra Lifesciences Holdings Corp at Citi Global Healthcare Conference Transcript

Dec 03, 2025 / 03:30PM GMT
Release Date Price: €11.5 (+1.77%)
Joanne Wuensch
Citi Infrastructure Investments LLC - Analyst

Thank you very much for joining us this morning. I am Joanne Wuensch, the Medical Technology Analyst here at Citibank and thrilled to have the management of Integra LifeSciences join us.

Questions & Answers

Joanne Wuensch
Citi Infrastructure Investments LLC - Analyst

One of the first questions when we were putting these together that came to me is that both of you are relatively new. And I'd love if you could just sort of give us a state of the union of what you've learned since you've arrived, what surprised you positively and what you're like, Hey, I didn't expect that.

Mojdeh Poul
Integra Lifesciences Holdings Corp - President, Chief Executive Officer, Director

Yes. Thank you so much for having us, Joanne, first of all, and I get started, and then I'll pass it on to Lea, but I would say one of the things that really got me attracted to the opportunity to begin with was the portfolio that we have. The strength of our portfolio, the brand

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot